Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Year: 2017
Type: review
Abstract: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide. It is associated with clinical states such as obesity, insulin resistance, and type 2 diabetes, and covers a wide range of liver changes, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular carcinoma. Metabolic disorders, such as lipid accumulation, insulin resistance, and inflammation, have been implicated in the pathogenesis of NAFLD, but the underlying mechanisms, including those that drive disease progression, are not fully understood. Both innate and recruited immune cells mediate the development of insulin resistance and NASH. Therefore, modifying the polarization of resident and recruited macrophage/Kupffer cells is expected to lead to new therapeutic strategies in NAFLD. Oxidative stress is also pivotal for the progression of NASH, which has generated interest in carotenoids as potent micronutrient antioxidants in the treatment of NAFLD. In addition to their antioxidative function, carotenoids regulate macrophage/Kupffer cell polarization and thereby prevent NASH progression. In this review, we summarize the molecular mechanisms involved in the pathogenesis of NAFLD, including macrophage/Kupffer cell polarization, and disturbed hepatic function in NAFLD. We also discuss dietary antioxidants, such as β-cryptoxanthin and astaxanthin, that may be effective in the prevention or treatment of NAFLD.
Source: Nutrients
DOI: 10.3390/nu9040387
Authors: Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota
Institution: Kanazawa University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: non-alcoholic fatty liver disease, insulin resistance, nonalcoholic steatohepatitis, macrophage polarization, Kupffer cells, oxidative stress, carotenoids, beta-cryptoxanthin, astaxanthin, dietary antioxidants, liver inflammation, lipid accumulation, obesity, type 2 diabetes, hepatocellular carcinoma, liver cirrhosis
Open Access status: gold
Estimated APC paid: $3,499
Awards: Research and development for energy expending anti-obesity functional food, Development of novel pharmacological treatments for nonalcoholic steatohepatitis: an application of carotenoid compound, Elucidating mechanisms specific to NASH-associated HCC development, Novel insight into the effects of carotenoids on non-alcoholic fatty liver disease
OpenAlex ID: W2605866155
